Market Overview

Why Alexion's Stock Is Trading Higher Today


Alexion Pharmaceuticals (NASDAQ: ALXN) shares are trading higher on Tuesday, on a report that Elliott Advisors sent a letter to the company seeking an immediate expiration of sales.

Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. The company is known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria.

Alexion Pharmaceuticals shares traded up 2.9% at $104.28 at time of publication. The stock has a 52-week high of $134.84 and a 52-week low of $72.67.

Related Links:

Alexion To Acquire Achillion Pharma For $930M

Alexion Confirms FDA Approval For Soliris


Related Articles (ALXN)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Movers Trading Ideas